Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Finished Goods: 2013-2025

Historic Finished Goods for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $279.6 million.

  • Phibro Animal Health's Finished Goods rose 63.76% to $279.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $279.6 million, marking a year-over-year increase of 63.76%. This contributed to the annual value of $253.8 million for FY2025, which is 49.69% up from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Finished Goods is $279.6 million, which was up 10.15% from $253.8 million recorded in Q2 2025.
  • Phibro Animal Health's Finished Goods' 5-year high stood at $279.6 million during Q3 2025, with a 5-year trough of $133.2 million in Q1 2021.
  • For the 3-year period, Phibro Animal Health's Finished Goods averaged around $208.2 million, with its median value being $184.6 million (2023).
  • In the last 5 years, Phibro Animal Health's Finished Goods decreased by 3.00% in 2024 and then soared by 63.76% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Finished Goods stood at $147.6 million in 2021, then climbed by 16.81% to $172.4 million in 2022, then increased by 7.05% to $184.6 million in 2023, then surged by 38.16% to $255.0 million in 2024, then skyrocketed by 63.76% to $279.6 million in 2025.
  • Its Finished Goods was $279.6 million in Q3 2025, compared to $253.8 million in Q2 2025 and $270.3 million in Q1 2025.